Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.
about
Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort studyA randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer.Survival of patients with symptom- and screening-detected colorectal cancer.Risk of cause-specific death in individuals with cancer - modifying role diabetes, statins, and metformin.Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer.Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.Physical activity and survival of colorectal cancer patients: Population-based study from Germany.No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.Topography of cancer-associated immune cells in human solid tumors
P2860
Q30241078-66D8BDB3-EF3F-4040-87D9-47BF259C85FCQ33767409-859A85F7-2539-4124-8156-F0B79B3D43EEQ36750940-2626139F-4386-4DBF-8133-432AFB5CBA3AQ37537002-8165655C-72CF-4DA9-8711-18BFDBD4F401Q38398847-0AC554BB-BD19-4B00-A766-E4ABD33A6318Q38617408-CAAF4458-DCCA-471D-8E17-EBE514B029ABQ38762741-13F18865-CB99-48E1-8F54-01EF1DE86855Q38859607-5FF2BF3A-1DFC-47B9-A091-5640A3AC695CQ39277021-285865ED-6E7C-4ADC-9717-3ECD47D4C3DBQ39317705-9A98AC89-AA61-41F8-94DC-6DC4EDFDBD1BQ40060735-D2279B5F-8E16-48DD-927F-20DE0817175BQ40365574-F956E6EE-5427-4D98-9CE7-4150F8A91C73Q40490322-05412E01-ABCD-4044-ABD2-2AAF8E11FDF7Q53476716-C80BBF08-3D0A-4F57-A811-63A430766B2BQ55429019-2B35F911-EBFB-424B-B206-3A94D7B33F83Q58423771-4D891819-2408-4539-AD63-0C701A9C7EF8
P2860
Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Statin use and survival after ...... hensive confounder adjustment.
@en
Statin use and survival after ...... hensive confounder adjustment.
@nl
type
label
Statin use and survival after ...... hensive confounder adjustment.
@en
Statin use and survival after ...... hensive confounder adjustment.
@nl
prefLabel
Statin use and survival after ...... hensive confounder adjustment.
@en
Statin use and survival after ...... hensive confounder adjustment.
@nl
P2093
P2860
P50
P356
P1476
Statin use and survival after ...... hensive confounder adjustment.
@en
P2093
Csaba Toth
Hendrik Bläker
Matthias Kloor
Wilfried Roth
P2860
P304
P356
10.1093/JNCI/DJV045
P407
P577
2015-03-13T00:00:00Z